Identification of MiR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer

Genes Chromosomes and Cancer

Volumn 50, Issue 10, 2011, Pages 812-822

  Võsa, Urmo ^a   Vooder, Tõnu ^b   Kolde, Raivo ^a   Fischer, Krista ^c   Välk, Kristjan ^a   Tõnisson, Neeme ^a,b   Roosipuu, Retlav ^b   Vilo, Jaak ^a   Metspalu, Andres ^a,c   Annilo, Tarmo ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 374A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EARLY CANCER; ESTONIA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DOWN-REGULATION; EARLY DIAGNOSIS; ESTONIA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80051559806     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20902     Document Type: Article

References (51)

1. Calin G, Liu C, Sevignani C, Ferracin M, Felli N, Dumitru C, Shimizu M, Cimmino A, Zupo S, Dono M, Dell'Aquila M, Alder H, Rassenti L, Kipps T, Bullrich F, Negrini M, Croce C. 2004. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755-11760.
2. Cheloufi S, Dos Santos C, Chong M, Hannon G. 2010. A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. Nature 465: 584-589.
3. Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y, Nie L, Xu M, Xia J, Zhao F, Meng W, Zhou Q. 2010. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res 70: 2728-2738.
4. Chiang H, Schoenfeld L, Ruby J, Auyeung V, Spies N, Baek D, Johnston W, Russ C, Luo S, Babiarz J, Blelloch R, Schroth G, Nusbaum C, Bartel D. 2010. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 24: 992-1009.
5. Cifuentes D, Xue H, Taylor D, Patnode H, Mishima Y, Cheloufi S, Ma E, Mane S, Hannon G, Lawson N, Wolfe S, Giraldez A. 2010. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 328: 1694-1698.
6. Crawford M, Batte K, Yu L, Wu X, Nuovo G, Marsh C, Otterson G, Nana-Sinkam S. 2009. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. Biochem Biophys Res Commun 388: 483-489.
7. Croce C. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
8. Davoren P, McNeill R, Lowery A, Kerin M, Miller N. 2008. Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76.
9. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth E, Lee W, Enders G, Mendell J, Thomas-Tikhonenko A. 2006. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
10. Du P, Kibbe W, Lin S. 2008. Lumi: A pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
11. Ebhardt H, Tsang H, Dai D, Liu Y, Bostan B, Fahlman R. 2009. Meta-analysis of small RNA-sequencing errors reveals ubiquitous post-transcriptional RNA modifications. Nucleic Acids Res 37: 2461-2470.
12. Fabian M, Sonenberg N, Filipowicz W. 2010. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351-379.
13. Fish J, Santoro M, Morton S, Yu S, Yeh R, Wythe J, Ivey K, Bruneau B, Stainier D, Srivastava D. 2008. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
14. Friedman J, Liang G, Liu C, Wolff E, Tsai Y, Ye W, Zhou X, Jones P. 2009. The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2. Cancer Res 69: 2623-2629.
15. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. 2010. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 64: 399-408.
16. Hand N, Master Z, Eauclaire S, Weinblatt D, Matthews R, Friedman J. 2009. The microRNA-30 family is required for vertebrate hepatobiliary development. Gastroenterology 136: 1081-1090.
17. Hatley M, Patrick D, Garcia M, Richardson J, Bassel-Duby R, van Rooij E, Olson E. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
18. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632.
19. Hong L, Lai M, Chen M, Xie C, Liao R, Kang Y, Xiao C, Hu W, Han J, Sun P. 2010. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res 70: 8547-8557.
20. Huang X, Ding L, Bennewith K, Tong R, Welford S, Ang K, Story M, Le Q, Giaccia A. 2009. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 35: 856-867.
21. Jemal A, Siegel R, Xu J, Ward E. 2010. Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
22. Kuhnert F, Mancuso M, Hampton J, Stankunas K, Asano T, Chen C, Kuo C. 2008. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development 135: 3989-3993.
23. Kumar M, Erkeland S, Pester R, Chen C, Ebert M, Sharp P, Jacks T. 2008. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105: 3903-3908.
24. Landi M, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen A, Rubagotti M, Goldstein A, Linnoila I, Marincola F, Tucker M, Bertazzi P, Pesatori A, Caporaso N, McShane L, Wang E. 2010. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin Cancer Res 16: 430-441.
25. Liu B, Peng X, Zheng X, Wang J, Qin Y. 2009. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer 66: 169-175.
26. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder T, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg R. 2010. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256.
27. Miska E, Alvarez-Saavedra E, Townsend M, Yoshii A, Sestan N, Rakic P, Constantine-Paton M, Horvitz H. 2004. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5: R68.
28. Mitchell P, Parkin R, Kroh E, Fritz B, Wyman S, Pogosova-Agadjanyan E, Peterson A, Noteboom J, O'Briant K, Allen A, Lin D, Urban N, Drescher C, Knudsen B, Stirewalt D, Gentleman R, Vessella R, Nelson P, Martin D, Tewari M. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518.
29. Mountain CF. 2000. The international system for staging lung cancer. Semin Surg Oncol 18: 106-115.
30. Navarro A, Marrades R, Viñolas N, Quera A, Agustí C, Huerta A, Ramirez J, Torres A, Monzo M. 2009. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. Oncology 76: 162-169.
31. Nelis M, Esko T, Mägi R, Zimprich F, Zimprich A, Toncheva D, Karachanak S, Piskácková T, Balascák I, Peltonen L, Jakkula E, Rehnström K, Lathrop M, Heath S, Galan P, Schreiber S, Meitinger T, Pfeufer A, Wichmann H, Melegh B, Polgár N, Toniolo D, Gasparini P, D'Adamo P, Klovins J, Nikitina-Zake L, Kucinskas V, Kasnauskiene J, Lubinski J, Debniak T, Limborska S, Khrunin A, Estivill X, Rabionet R, Marsal S, Julià A, Antonarakis S, Deutsch S, Borel C, Attar H, Gagnebin M, Macek M, Krawczak M, Remm M, Metspalu A. 2009. Genetic structure of Europeans: A view from the North-East. PLoS One 4: e5472.
32. Patrick D, Zhang C, Tao Y, Yao H, Qi X, Schwartz R, Jun-Shen Huang L, Olson E. 2010. Defective erythroid differentiation in miR-451 mutant mice mediated by 14-3-3zeta. Genes Dev 24: 1614-1619.
33. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe S, Croce C, Dejean A. 2010. miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA 107: 264-269.
34. Quigley D, Balmain A. 2009. Systems genetics analysis of cancer susceptibility: From mouse models to humans. Nat Rev Genet 10: 651-657.
35. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer D. 2009. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69: 5776-5783.
36. Reinhart B, Slack F, Basson M, Pasquinelli A, Bettinger J, Rougvie A, Horvitz H, Ruvkun G. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901-906.
37. Ryan B, Robles A, Harris C. 2010. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
38. Schaefer A, Stephan C, Busch J, Yousef G, Jung K. 2010. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7: 286-297.
39. Seike M, Goto A, Okano T, Bowman E, Schetter A, Horikawa I, Mathe E, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce C, Harris C. 2009. MiR-21 is an EGF-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci USA 106: 12085-12090.
40. Song G, Zhang Y, Wang L. 2009. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 284: 31921-31927.
41. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756.
42. Thomson J, Parker J, Perou C, Hammond S. 2004. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53.
43. Tian S, Huang S, Wu S, Guo W, Li J, He X. 2010. MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region. Biochem Biophys Res Commun 396: 435-439.
44. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
45. Välk K, Vooder T, Kolde R, Reintam MA, Petzold C, Vilo J, Metspalu A. 2010. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers. Oncology 79: 283-292.
46. Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt R, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris C, Croce C. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261.
47. Wang H, Ruan H, He X, Ma Y, Jiang X, Xia Y, Ye Z, Tao H. 2010. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur J Cancer 46: 2295-2303.
48. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens R, Okamoto A, Yokota J, Tanaka T, Calin G, Liu C, Croce C, Harris C. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
49. Yang Y, Li X, Yang Q, Wang X, Zhou Y, Jiang T, Ma Q, Wang Y. 2010. The role of microRNA in human lung squamous cell carcinoma. Cancer Genet Cytogenet 200: 127-133.
50. Yu D, dos Santos C, Zhao G, Jiang J, Amigo J, Khandros E, Dore L, Yao Y, D'Souza J, Zhang Z, Ghaffari S, Choi J, Friend S, Tong W, Orange J, Paw B, Weiss M. 2010. miR-451 protects against erythroid oxidant stress by repressing 14-3-3zeta. Genes Dev 24: 1620-1633.
51. Yu S, Chen H, Chang G, Chen C, Chen H, Singh S, Cheng C, Yu C, Lee Y, Chen H, Su T, Chiang C, Li H, Hong Q, Su H, Chen C, Chen W, Liu C, Chan W, Li K, Chen J, Yang P. 2008. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13: 48-57.